What are the Challenges of Anti-Angiogenic Therapy?
While anti-angiogenic therapies have shown promise, they are not without challenges. Tumors can develop resistance to these treatments by activating alternative angiogenic pathways or adapting to hypoxic conditions. Additionally, the inhibition of blood vessel formation can sometimes exacerbate tumor hypoxia, leading to more aggressive cancer behavior.
